| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Former CEO | President &CEO +2 more
2 companies
Andrews Ronald Asbury is a Former CEO at Insight Molecular Diagnostics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | IMDX Insight Molecular Diagnostics Inc. | President &CEO | Buy | 40,000 | $0.96 | $38,400.00 | +13.6% | -55.2% | -81.8% | |
| Mar 16, 2022 | IMDX Insight Molecular Diagnostics Inc. | Chief Executive Officer | Buy | 50,000 | $1.28 | $64,150.00 | +20.6% | -10.8% | -74.8% | |
| Mar 19, 2021 | IMDX Insight Molecular Diagnostics Inc. | Chief Executive Officer | Buy | 11,000 | $4.79 | $52,702.10 | +10.7% | +17.2% | -66.7% | |
| Aug 3, 2020 | IMDX Insight Molecular Diagnostics Inc. | Chief Executive Officer | Buy | 40,000 | $1.35 | $53,880.00 | +63.8% | - | - | |
| Mar 31, 2020 | IMDX Insight Molecular Diagnostics Inc. | CEO And President | Buy | 45,216 | $945.63 | $42,757,453.73 | +72.7% | - | - | |
| Jul 26, 2018 | IMDX Insight Molecular Diagnostics Inc. | Director | Buy | 17,482 | $0.00 | - | New | - | - |